$ALPS

12 Health Care Stocks Moving In Monday's After-Market Session

This article details the after-market performance of 12 healthcare stocks on Monday. It lists both gainers, such as ALPS Group and NeuroOne Medical Technologies, and losers, including Anebulo Pharmaceuticals and Invivyd, along with their respective percentage changes and market capitalizations.

Original reporting
Benzinga · Benzinga Insights
Published Dec 23, 2025, 7:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Dec 23, 2025, 7:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
12 Health Care Stocks Moving In Monday's After-Market Session — source image
Decision brief

The 30-second read

$ALPSBullishMed
01

Why it matters

Short-term trading opportunities exist based on recent movements, but limited fundamental data reduces confidence.

02

Market read

The stocks discussed have varying relevance; gainers present potential short-term opportunities, while losers warrant caution.

03

What to watch

Broader market conditions, upcoming earnings reports, and sector-wide developments could significantly influence these stocks beyond recent after-market movements.

Timing: short-term (next 1-3 days)

Background

The article summarizes after-market performance of 12 healthcare stocks, highlighting both gainers and losers.

Company-level read

Ticker impact

$ALPSBullishMedium confidence
Context

Gainer in after-market session; potential positive momentum.

Expected impact

Moderate increase (~3-5%) in the near term.

Evidence & confidence

Recent after-market performance suggests positive investor sentiment, but lack of broader market confirmation limits certainty.

$ANEBBearishLow confidence
Context

Low relevance; sentiment score indicates somewhat-bearish outlook.

Expected impact

Minimal impact; unlikely to influence broader market.

Evidence & confidence

Low relevance score and lack of technical data imply limited actionable insight.

Market effects

Healthcare sector showing mixed signals; some stocks indicating short-term bullishness, others cautious.

Limited regional impact; focus remains on individual stock performance.

Minimal; news pertains to specific stocks without broader global implications.

Counterpoint

The decline in some stocks may be temporary; positive news catalysts could reverse short-term trends.

Key entities

  • ALPS Group

    A healthcare company experiencing after-market gains.

  • NeuroOne Medical Technologies

    A medical technology firm with positive after-market movement.

  • Anebulo Pharmaceuticals

    A pharmaceutical company with declining after-market performance.

  • Invivyd

    A biotech firm showing a post-market decline.

Related articles

$FLYMedAI 8/10

SciTec wins $94M Space Force contract – BizWest

SciTec, a subsidiary of Firefly Aerospace (Nasdaq: FLY), won a nearly $94 million U.S. Space Force contract to supply ground-based radar digitization for Space Systems Command in Colorado Springs. SciTec said the work will modernize radars via a common architecture and design. SciTec was absorbed into Firefly last year for $855 million.

$TSNMed

Tyson, JBS to slash slaughter capabilities

Tyson Foods said it will close its Joslin, Illinois harvest plant and a Utah case-ready facility, and plans to sell a harvest facility in Pasco, Washington, citing U.S. cattle shortages. Tyson will anchor beef around Dakota City, Nebraska; Holcomb, Kansas; and Amarillo, Texas. JBS plans to shift Souderton, Pennsylvania to case-ready and invest $30 million. Analysts link closures to lower cattle prices and packer concentration.

$UWMCMed

UWM sued for allegedly misleading investors on hedge strategy

Shareholder Doug Bond filed a class action against UWM Holdings in Michigan federal court, alleging securities fraud over disclosures about UWM’s interest rate derivatives hedge tied to its Two Harbors acquisition. The suit covers purchases from March 9 to Aug. 5, citing a $603.2 million derivatives loss and a $2.05 billion Oaktree cash infusion after a March revenue projection.

$BAMedAI 8/10

Pentagon inks deals with Boeing, RTX to boost production of SM-3 components

The Pentagon signed seven-year framework agreements with Boeing and RTX to expand production of Standard Missile-3 components for SM-3 Block IB and Block IIA, including avionics and ejector assemblies Boeing supplies to Raytheon. The deals aim to stabilize supply chains and expand munitions output. Separately, the Missile Defense Agency awarded Raytheon a $745 million contract for Block IIA interceptors.

$BCLIMed

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics (OTCQB: BCLI) reported Q2 2026 results for the quarter ended June 30, 2026. It said it is preparing to start the Phase 3b ENDURANCE study of NurOwn in ALS under an FDA-agreed Special Protocol Assessment, planning about 200 patients. Cash was about $0.2M vs $1.03M a year earlier, with Q2 net loss about $3.9M. The company appointed Peter J. Pitts as Executive Chairman and raised about $400k in private placements.

$MARAMed

Crypto Biz: Bitcoin ETFs Rebound as Crypto Miners Extend AI Pivot

A $116 million Coldcard hardware wallet exploit renewed scrutiny of self-custody as US spot Bitcoin ETFs saw about $1 billion in net inflows for the week, according to Bloomberg. Strategy CEO Phong Le said Strategy will resume Bitcoin accumulation later this year; Riot Platforms reported a 20-year $9 billion compute deal with Anthropic. Trump Media plans to revamp its crypto treasury after a $238 million Q2 net loss.